Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Discover which stablecoins pay interest safely and how to assess counterparty risk. This guide helps you compare options and reduce exposure while earning yields.
24,010 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A dividend-focused ETF beats a broad market gain on yield and stability. Invesco’s SPHD offers 4.57% income with lowe...
Savers are exploring dividend income to take home an electrician’s paycheck, but the capital required hinges on yield...
The U.S. has removed foreign-access restrictions on Anthropic’s Claude 3.5 and Fable 5, signaling a renewed AI leader...
A revival in small-cap stocks is taking shape as three key forces converge. AI-driven demand, a steadier macro backdr...
A wave of large institutions is expanding bitcoin exposure through regulated products and custody services, signaling...
President Trump’s Mount Rushmore appearance on Independence Day stirred political headlines and market caution. Early...
Prediction-market traders are pricing a US edge after Balogun’s clearance to play in the World Cup round-of-16. Marke...
Bitcoin climbs in early July trading, but analysts caution that liquidity gaps and a large underwater supply could ca...
AngelList is terminating its Rail partnership with Ripple, ending crypto payments on the platform by July 31, 2026. T...
Palantir faced a sharp 34% drop in the first half of 2026 as AI market expectations and earnings jitters weighed on s...
The 2026 RealTrends Verified City Rankings reveal where the industry’s top agents are expanding, highlighting how sca...